R1 RCM Inc (RCM)

Currency in USD
14.31
0.00(0.00%)
Closed·
Showing R1 RCM historical data. For real-time data please try another search
Day's Range
14.3014.32
52 wk Range
10.5714.32
Key Statistics
Prev. Close
14.31
Open
14.3
Day's Range
14.3-14.32
52 wk Range
10.57-14.32
Volume
-
Average Volume (3m)
2.79M
1-Year Change
1.85%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

R1 RCM Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

R1 RCM Inc Company Profile

R1 RCM Inc. provides managed and automated healthcare revenue management solutions. The company develops and provides R1 platform, which integrates AI, intelligent automation and deep data analytics for healthcare through proprietary RCM optimization engines that turn complex data into financial and operating performance improvements. It also offers enterprise solutions, which offer full-service revenue cycle management services; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. R1 RCM Inc. was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. The company was founded in 2003 and is based in Murray, Utah. R1 RCM Inc. operates as a subsidiary of Raven Acquisition Holdings, LLC.

R1 RCM Inc SWOT Analysis


AI-Driven Evolution
Explore R1 RCM's strategic integration of AI and automation, positioning the company at the forefront of healthcare revenue cycle management innovation
Cyber Resilience
Delve into R1 RCM's response to industry-wide cybersecurity challenges, including potential financial impacts and emerging opportunities in denial management
Valuation Insights
Analysts set an average price target of $161, with R1 RCM trading at an attractive EV/EBITDA ratio of 2.81x, suggesting potential undervaluation
Strategic Horizons
Uncover the implications of R1 RCM's ongoing strategic review, including potential take-private scenarios and their impact on long-term growth prospects
Read full SWOT analysis

R1 RCM Inc Earnings Call Summary for Q2/2024

  • Q2 revenue: $627.9M, adjusted EBITDA: $156.1M; strong despite cyberattacks on partners
  • Acclara integration on track; Ascension cyberattack resolved, expecting normalcy soon
  • Cyberattack delayed $75M-$95M revenue; cash position strong at $163M
  • No 2024 guidance due to pending transaction; recovery expected in 2025
  • Net operating fees up 5%, Modular revenue up 35%; incentive fees below expectations
Last Updated: 08/08/2024, 11:24
Read Full Transcript

Earnings

Latest Release
Feb 13, 2025
EPS / Forecast
-0.05 / 0.105
Revenue / Forecast
656.80M / 709.08M
EPS Revisions
Last 90 days

RCM Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.